Milestones | Achievements

Milestones to your success

Scope International has contributed to the success of many individual projects; we are particularly proud when this teamwork with our Sponsors leads to achieving product registration, the ultimate goal of clinical development.

Over the years, we have conducted a number of pivotal studies in asthma, epilepsy, pain and pneumology that have resulted in European and US marketing authorisations:

2013

  • marketing authorisation granted for an anticonvulsant in the US (epilepsy)
  • marketing authorisation granted for an innovative new inhalation device for patients with asthma and/or chronic obstructive pulmonary disease (COPD) in Europe

2011

  • marketing authorisation granted for an opioid in the US (moderate to severe pain)

2010

  • marketing authorisation granted for an opioid in Europe (moderate to severe pain relief)

2009

  • marketing authorization granted for an anticonvulsant (epilepsy) in Europe

2004

  • marketing authorisation granted for a long-acting beta-agonist (asthma) in Europe

2002

  • marketing authorisation granted for an anti-infective drug (pneumology) in Europe

Print Friendly
grafikbohneMilestones | Achievements